11365818

Source:http://linkedlifedata.com/resource/pubmed/id/11365818

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0015677, umls-concept:C0035525, umls-concept:C0080045, umls-concept:C0205540, umls-concept:C0549177
pubmed:issue	No 37
pubmed:dateCreated	1999-5-17
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9300979
pubmed:citationSubset	X
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha, http://linkedlifedata.com/resource/pubmed/chemical/Ribavirin
pubmed:status	MEDLINE
pubmed:author	pubmed-author:FalkenbergJJ
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	10-1
pubmed:dateRevised	2004-11-17
pubmed:meshHeading	pubmed-meshheading:11365818-Antiviral Agents, pubmed-meshheading:11365818-Drug Approval, pubmed-meshheading:11365818-Drug Packaging, pubmed-meshheading:11365818-Drug Therapy, Combination, pubmed-meshheading:11365818-Hepatitis C, pubmed-meshheading:11365818-Humans, pubmed-meshheading:11365818-Interferon-alpha, pubmed-meshheading:11365818-Ribavirin, pubmed-meshheading:11365818-United States, pubmed-meshheading:11365818-United States Food and Drug Administration, pubmed-meshheading:11365818-Viral Load
pubmed:articleTitle	Ribavirin approved with a big fat price.
pubmed:publicationType	Newspaper Article